TY  - GEN
AU  - Chen,Allen M
AU  - Felix,Carol
AU  - Wang,Pin-Chieh
AU  - Hsu,Sophia
AU  - Basehart,Vincent
AU  - Garst,Jordan
AU  - Beron,Phillip
AU  - Wong,Deborah
AU  - Rosove,Michael H
AU  - Rao,Shyam
AU  - Melanson,Heather
AU  - Kim,Edward
AU  - Palmer,Daphne
AU  - Qi,Lihong
AU  - Kelly,Karen
AU  - Steinberg,Michael L
AU  - Kupelian,Patrick A
AU  - Daly,Megan E
TI  - Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
SN  - 1474-5488
PY  - 2017///0824
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carboplatin
KW  - administration & dosage
KW  - Carcinoma, Squamous Cell
KW  - drug therapy
KW  - Chemoradiotherapy
KW  - Deglutition Disorders
KW  - etiology
KW  - Disease-Free Survival
KW  - Follow-Up Studies
KW  - Human papillomavirus 16
KW  - Humans
KW  - Induction Chemotherapy
KW  - Leukopenia
KW  - chemically induced
KW  - Male
KW  - Middle Aged
KW  - Mucositis
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - diagnosis
KW  - Neoplasm Staging
KW  - Neutropenia
KW  - Oropharyngeal Neoplasms
KW  - Paclitaxel
KW  - Papillomavirus Infections
KW  - complications
KW  - Radiotherapy Dosage
KW  - Response Evaluation Criteria in Solid Tumors
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S1470-2045(17)30246-2
ER  -